| RS727503762 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy 1 with immunodeficiency, Polyglucosan body myopathy 1 with immunodeficiency |
| RS727503763 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy 1 with immunodeficiency, Polyglucosan body myopathy 1 with immunodeficiency |
| RS727503764 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy type 1 |
| RS727503765 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy type 1 |
| RS727503766 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS727503767 |
NIPBL
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 1, NIPBL-related disorder |
| RS727503768 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS727503769 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS727503770 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS727503771 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS727503772 |
NIPBL
|
Health Risk |
Pathogenic/Likely pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS727503773 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, 6 conditions |
| RS727503774 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Wiedemann-Steiner syndrome |
| RS727503775 |
SMC3
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 3, Wiedemann-Steiner syndrome |
| RS727503776 |
SMC1A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS727503777 |
KMT2A
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS727503778 |
TAF6
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Alazami-Yuan syndrome |
| RS727503779 |
LRBA
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS727503780 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS727503781 |
WDPCP
|
Health Risk |
Pathogenic |
Heart defect - tongue hamartoma - polysyndactyly syndrome, Bardet-Biedl syndrome |
| RS727503782 |
ELN
|
Health Risk |
Pathogenic/Likely pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS727503783 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS727503784 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS727503785 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS727503786 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS727503788 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS727503789 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS727503791 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS727503794 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS727503795 |
ACAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS727503796 |
ACAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS727503797 |
ACTA1
|
Health Risk |
Likely pathogenic |
ACTA1-related disorder, ACTA1-related disorder |
| RS727503798 |
ACTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Actin accumulation myopathy, Congenital myopathy 2c |
| RS727503799 |
AIPL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS727503802 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Thyroid cancer |
| RS727503807 |
AP1S2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727503809 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, ARSB-related disorder |
| RS727503811 |
ASL
|
Health Risk |
Conflicting classifications of pathogenicity |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS727503812 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS727503814 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia type I, Citrullinemia |
| RS727503815 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS727503818 |
BBS10
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 10 |
| RS727503821 |
BBS7
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 7 |
| RS727503822 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS727503824 |
BEST1
|
Health Risk |
Pathogenic |
Stargardt disease, Vitelliform macular dystrophy 2 |
| RS727503826 |
BCOR
|
Health Risk |
Pathogenic |
— |
| RS727503827 |
BCOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS727503828 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS727503830 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS727503832 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS727503833 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS727503835 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS727503836 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS727503837 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS727503838 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS727503839 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy |
| RS727503840 |
CASK
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, CASK-related |
| RS727503841 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS727503844 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS727503846 |
CDKL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS727503850 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS727503852 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Joubert syndrome |
| RS727503853 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome 5, Nephronophthisis |
| RS727503854 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS727503855 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS727503857 |
CERKL
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS727503858 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS727503859 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHD7-related disorder |
| RS727503860 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHD7-related disorder |
| RS727503861 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS727503862 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS727503863 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS727503864 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS727503865 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS727503866 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS727503867 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS727503868 |
MED12
|
Health Risk |
Pathogenic/Likely pathogenic |
Blepharophimosis - intellectual disability syndrome, MKB type |
| RS727503869 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, FG syndrome |
| RS727503870 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Inborn genetic diseases |
| RS727503871 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS727503872 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Walker-Warburg congenital muscular dystrophy |
| RS727503873 |
POMT2
|
Health Risk |
Pathogenic |
— |
| RS727503877 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS727503878 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism, susceptibility to |
| RS727503881 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS727503882 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS727503883 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1B |
| RS727503884 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS727503885 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727503887 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS727503889 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS727503893 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS727503894 |
CRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 2, Leber congenital amaurosis 7 |
| RS727503895 |
DBT
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, DBT-related disorder |
| RS727503896 |
DBT
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS727503897 |
DCX
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS727503898 |
DCX
|
Health Risk |
Pathogenic |
— |
| RS727503899 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS727503900 |
DLG3
|
Health Risk |
Pathogenic |
— |
| RS727503901 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, DNAH11-related disorder |